Sign in
4

Changes in Ownership

Tonix Pharmaceuticals Holding Corp. Filed Acc 0001387131-22-002105

Options or other derivatives

  • Chief Executive Officer acquired 20,000,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

LEDERMAN SETH · Chief Executive Officer

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2022-02-15 Grant or award : show line 1 in the form Stock Option +5,000,000 5,000,000 D
2022-02-15 Grant or award : show line 2 in the form Stock Option +5,000,000 5,000,000 D
2022-02-15 Grant or award : show line 3 in the form Stock Option +5,000,000 5,000,000 D
2022-02-15 Grant or award : show line 4 in the form Stock Option +5,000,000 5,000,000 D
Loading xslF345X03/lederman-form4_021522.xml…